Simplex Trading’s Kymera Therapeutics KYMR Stock Holding History

Simplex Trading’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$577K	Sell	5,165 -702	-12%	-$80.4K	﹤0.01%	3383
2026 Q2	$673K	Buy	+5,867	New	+$504K	﹤0.01%	3253
2025 Q1	–	Sell	-20	Closed	-$729	–	9106
2024 Q4	$0	Buy	+20	New	+$903	﹤0.01%	9112
2022 Q4	–	Sell	-3,922	Closed	-$105K	–	9832
2022 Q3	$85K	Buy	3,922 +3,646	+1,321%	+$96.1K	﹤0.01%	5743
2022 Q2	$5K	Sell	276 -3,449	-93%	-$80.6K	﹤0.01%	8833
2022 Q1	$157K	Buy	3,725 +3,720	+74,400%	+$157K	﹤0.01%	5505
2021 Q4	$0	Sell	5 -1,355	-100%	-$78.9K	﹤0.01%	10958
2021 Q3	$76K	Buy	1,360 +1,018	+298%	+$59K	﹤0.01%	6995
2021 Q2	$16K	Buy	+342	New	+$14.8K	﹤0.01%	8768

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Simplex Trading's KYMR Position: Q3 2026 in Review

Simplex Trading reduced its Kymera Therapeutics (KYMR) stake by 12% in Q3 2026, selling an estimated $80.4K and leaving 5,165 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #3383.

Simplex Trading first reported a position in KYMR in Q2 2021 and has held it in 9 quarters since. The position peaked at $673K in Q2 2026. 173 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

Simplex Trading held 5,165 shares of Kymera Therapeutics worth $577K as of Q3 2026.
Simplex Trading sold 702 Kymera Therapeutics shares in Q3 2026, an estimated $80.4K.
Kymera Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #3383 holding.
Simplex Trading first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 9 quarters since.
Simplex Trading's Kymera Therapeutics position peaked at $673K in Q2 2026.
173 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.